An open letter to the FDA and other regulatory agencies: Preclinical drug development must consider the impact on metastasis.

Author

Patricia Steeg, Robin Anderson, Menashe Bar-Eli, Ann Chambers, Suzanne Eccles, Kent Hunter, Kazuyuki Itoh, Yibin Kang, Lynn Matrisian, Jonathan Sleeman, Dan Theodorescu, Erik Thompson, Danny Welch

Publication Year

2009

Type

Journal Article

Journal

Clin Cancer Res

Volume

Pages

4529

Date Published

07/2009

ISSN Number

1078-0432

DOI

Alternate Journal

Clin. Cancer Res.

PMID

25278743